EPS1.4 Real life acute changes in spirometric indices after lumacaftor/ivacaftor first administration in pediatric patients with cystic fibrosis

Autor:	A. Labaste, M.-C. Werck-Gallois, A. Toutain-Rigolet, Philippe Reix, Laurianne Coutier, S. Vrielynck, M. Perceval, Catherine Mainguy, V. Jubin
Rok vydání:	2017
Předmět:	Pulmonary and Respiratory Medicine Pediatrics medicine.medical_specialty business.industry Lumacaftor medicine.disease Cystic fibrosis Ivacaftor chemistry.chemical_compound chemistry Pediatrics Perinatology and Child Health medicine business Intensive care medicine medicine.drug
Zdroj:	Journal of Cystic Fibrosis. 16:S36-S37
ISSN:	1569-1993
DOI:	10.1016/s1569-1993(17)30277-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::954b3544b653917b5f102c98211adf7a https://doi.org/10.1016/s1569-1993(17)30277-1 Zobrazit plný text záznamu Full Text from ScienceDirect